Britain to offer all infants meningitis B vaccine

Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC.

Government health advisers recommended use of the Bexsero vaccine last year, and the government has spent months negotiating over the cost.

The drug was owned by Novartis, which recently sold most of its vaccines business to GlaxoSmithKline.

Health Secretary Jeremy Hunt said Sunday he was "very proud that we will be the first country in the world to have a nationwide Men B vaccination program."

Babies will receive the vaccine at two months, followed by two further doses.

Meningitis is a of the lining surrounding the brain and that most commonly affects children and teenagers.


Explore further

FDA approves second vaccine against meningitis strain

© 2015 The Associated Press. All rights reserved.

Citation: Britain to offer all infants meningitis B vaccine (2015, March 29) retrieved 22 September 2019 from https://medicalxpress.com/news/2015-03-britain-infants-meningitis-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
14 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more